SYSTEMS AND METHODS FOR MONITORING AN INDIVIDUAL'S HEALTH

1 . A metabolic urine core test platform comprising: a model; a physiologic fluid; a test panel comprising a biomarker assay; an instrument; and a computer, the computer further comprising program instructions written on a non-transient computer-readable media for performing a method of monitoring at least one biomarker.

2 . The metabolic urine core test platform of claim 1 , wherein the model comprises human individuals classified into groups.

3 . The metabolic urine core test platform of claim 2 , wherein the groups are selected from the group consisting of normal adult, a workplace worker, an elderly person, an athlete and a dieter.

4 . The metabolic urine core test platform of claim 2 , wherein the physiologic fluid comprises urine and the biomarker assay comprises a urinary test strip, the test strip further comprising a urinary normalization assay arranged on the same strip with the biomarker assay, wherein the assays comprise chemical, enzymatic or immunochemical assays.

5 . The metabolic urine core test platform of claim 4 , wherein the test strip comprises a critical combination of biomarker assays in addition to the urinary normalization assay, wherein the critical combination of biomarker assays is determined by selection of the group of individuals.

6 . The metabolic urine core test platform of claim 5 , wherein the critical combination of biomarker assays relate to at least one of oxidative stress, antioxidant capacity, inflammation, and toxicity of the individual.

7 . The metabolic urine core test platform of claim 4 , wherein the instrument comprises a portable or handheld assay reading device comprising a colorimeter for reading color on the assays.

8 . The metabolic urine core test platform of claim 5 , wherein the computer comprises a PED and the program instructions written on the non-transient computer-readable media comprise an app downloadable to the non-transient computer-readable media of the PED.

9 . The metabolic urine core test platform of claim 8 , wherein the instrument electronically connects to the PED by hardwire or Bluetooth, to enable data transfer from the instrument to the non-transient computer-readable media of the PED.

10 . The metabolic urine core test platform of claim 1 , wherein the method of monitoring comprises:

obtaining the physiologic fluid sample from the individual;

wetting the test panel with the physiologic fluid sample to create a wetting test panel;

inserting the wetted test panel into the instrument;

transferring data from the instrument to the non-transient computer-readable media of the computer; and

analyzing the data to provide an assessment of the individual's health.

11 . A system for monitoring health of an individual comprising:

a urinary test strip comprising a combination of biomarker assays and a urinary normalization assay, the assays positioned and spaced apart on the strip;

an assay reading device comprising a colorimeter, the device configured for physical insertion of the urinary test strip therein, the colorimeter configured for obtaining colorimetric data from the assays; and

a computer comprising program instructions written on a non-transient computer-readable media for performing transfer of the data from the assay reading device to the non-transient computer-readable media of the computer and analysis of the data to provide the health of the individual.

12 . The system of claim 11 , wherein the individual is selected from the group consisting of a normal adult, a workplace worker, an elderly person, an athlete, and a dieter.

13 . The system of claim 11 , wherein the biomarker assays and the urinary normalization assay are selected from dry reagent test pads and/or lateral flow immunoassays.

14 . The system of claim 11 , wherein the urinary normalization assay comprises a urinary creatinine assay.

15 . The system of claim 11 , wherein the computer comprises a PED.

16 . The system of claim 12 , wherein the group comprises the normal adult, the combination of biomarker assays comprises MDA, PDX, CUPRAC, UTI, PRO, Ketone, pH, and the urinary normalization assay comprises a urinary creatinine assay.

17 . The system of claim 12 , wherein the group comprises the workplace worker, the combination of biomarker assays comprises MDA, PDX, CUPRAC, UTI, PRO, Ketone, pH, and the urinary normalization assay comprises a urinary creatinine assay.

18 . The system of claim 12 , wherein the group comprises the elderly, the combination of biomarker assays comprises MDA, UTI, PRO, Glucose, Electrolytes, Blood, Bilirubin, Leukocytes, and the urinary normalization assay comprises a urinary creatinine assay.

19 . The system of claim 12 , wherein the group comprises the athlete, the combination of biomarker assays comprises a urinary creatinine assay, MDA, PDX, CUPRAC, UTI, Ketone, Fat metabolizing, Muscle efficiency, Nitrite/Nitrate, and the urinary normalization assay comprises a specific gravity measurement.

20 . The system of claim 12 , wherein the group comprises the dieter, the combination of biomarker assays comprises MDA, PDX, UTI, PRO, Ketone, pH, Fat metabolizing, Electrolytes, and the urinary normalization assay comprises a urinary creatinine assay.

21 . A method of monitoring an individual's health, the method comprising:

obtaining a urine sample from the individual;

wetting a urinary test strip with the urine sample;

inserting the wetted urinary test strip into an instrument in communication with a computer and configured to read data from the wetted urinary test strip when inserted therein;

reading the data from the wetted urinary test strip;

transferring the data from the instrument to a non-transitory computer-readable media of the computer; and

analyzing the data to obtain the individual's health,

wherein program instructions for performing the method are written on the non-transitory computer-readable media.

22 . The method of claim 21 , wherein the urinary test strip further comprises a combination of biomarker assays and one urinary normalization assay.

23 . The method of claim 22 , wherein the individual is classified into at least one group based on age and/or lifestyle, and wherein the combination of biomarker assays is determined by the nature of the group.

24 . The method of claim 23 , wherein the group is selected from normal adult, workplace worker, elderly, athlete and dieter.

25 . The method of claim 24 , wherein the instrument comprises an assay reading device further comprising colorimetry capability for reading color from the combination of biomarker assays and one urinary normalization assay.

26 . The method of claim 24 , wherein the group comprises the normal adult, the combination of biomarker assays comprises MDA, PDX, CUPRAC, UTI, PRO, Ketone, pH, and the urinary normalization assay comprises a urinary creatinine assay.

27 . The method of claim 24 , wherein the group comprises the workplace worker, the combination of biomarker assays comprises MDA, PDX, CUPRAC, UTI, PRO, Ketone, pH, and the urinary normalization assay comprises a urinary creatinine assay.

28 . The method of claim 24 , wherein the group comprises the elderly, the combination of biomarker assays comprises MDA, UTI, PRO, Glucose, Electrolytes, Blood, Bilirubin, Leukocytes, and the urinary normalization assay comprises a urinary creatinine assay.

29 . The method of claim 24 , wherein the group comprises the athlete, the combination of biomarker assays comprises MDA, PDX, CUPRAC, UTI, Ketone, Fat metabolizing, Muscle efficiency, Nitrite/Nitrate, and the urinary normalization assay comprises a specific gravity measurement.

30 . The method of claim 24 , wherein the group comprises the dieter, the combination of biomarker assays comprises MDA, PDX, UTI, PRO, Ketone, pH, Fat metabolizing, Electrolytes, and the urinary normalization assay comprises a urinary creatinine assay.